Path Corporation (TYO:3840)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Investment Business	12.15M	-	-	-	-
Unallocated Adjustment	-	-12.00K	-4.72M	-	-
Ai and Technology Business	5.84M	-	-	-	-
Cosmetics Business	798.71M	-	-	-	-
Market Expansion Business	7.60M	-	-	-	-
Regenerative Medicine Related Business ( Excluding Sustainable Business)	364.02M	409.43M	-	-	-
Regenerative Medicine Related Business ( Excluding Sustainable Business) Growth	-11.09%	-	-	-	-
Sustainable Business	22.14M	42.21M	-	-	-
Sustainable Business Growth	-47.55%	-	-	-	-
Beauty & Wellness Business	1.04B	-	-	-	-
Cosmetics, Beauty and Wellness Business	-	1.87B	1.94B	2.11B	2.21B
Cosmetics, Beauty and Wellness Business Growth	-	-3.66%	-8.26%	-4.26%	-6.70%
Sustainable and Regenerative Medicine Business	-	-	57.35M	450.00K	-
Sustainable and Regenerative Medicine Business Growth	-	-	12643.33%	-	-
Total	2.25B	2.32B	1.99B	2.11B	2.21B
Total Growth	-2.86%	16.47%	-5.79%	-4.24%	-11.11%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Japan	2.25B	2.32B	1.99B	2.11B	2.21B
Japan Growth	-2.89%	16.52%	-5.82%	-4.26%	-11.08%
Total	2.25B	2.32B	1.99B	2.11B	2.21B
Total Growth	-2.89%	16.52%	-5.82%	-4.26%	-11.08%

Source: S&P Global Market Intelligence.